Showing results (361-370 of 444) with videos related to

Sort By:
Pageof 45
Respiratory Medicine|May 16, 2017
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseJulie Morisset, Eric Vittinghoff, Bo Young Lee, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
American Journal of Respiratory and Critical Care Medicine|April 15, 2022
Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung AbnormalitiesYuchen Zhang, Huajing Wan, Luca Richeldi, et al.
Thorax|December 26, 2013
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trialsLesley Ann Saketkoo, Shikha Mittoo, Dörte Huscher, et al.
Chest|November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung DiseaseAlessia Comes, Alyson W Wong, Jolene H Fisher, et al.
Elife|July 4, 2018
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosisMark G Jones, Orestis G Andriotis, James Jw Roberts, et al.
ERJ Open Research|September 24, 2025
Online home spirometry in national pulmonary fibrosis care: insights from daily practiceGizal Nakshbandi, Catharina C Moor, Tonia Magrì, et al.
Frontiers in Molecular Biosciences|April 19, 2021
Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial-Mesenchymal TransitionYilu Zhou, Charlotte Hill, Liudi Yao, et al.
ERJ Open Research|July 13, 2026
Beneficial effects of the AT2 receptor agonist buloxibutid (C21) against acute alveolar epithelial cell inflammation during antiviral responsesFranco Conforti, Joseph Bell, Robert Ridley, et al.
The New England Journal of Medicine|October 1, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Pageof 45